GREEN MOUNTAIN STRATEGIES LLC DC

Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $30,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

General education regarding pandemic preparedness

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.